Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

Poster display

3943 - A prospective analysis of quality of life (QoL), cognitive functions (CF) and psychological status (PSY) in glioblastoma (GBM) patients (PTS) treated with RT and temozolomide (TMZ)


09 Oct 2016


Poster display


eleonora Bergo


Annals of Oncology (2016) 27 (6): 103-113. 10.1093/annonc/mdw367


E. Bergo1, G. Lombardi1, P. Del Bianco2, F. Berti3, L. Bellu1, A. Pambuku1, V. Zagonel1

Author affiliations

  • 1 Department Of Clinical And Experimental Oncology, Medical Oncology 1, Veneto Institute of Oncology - IRCCS, 35100 - Padova/IT
  • 2 Clinical Trials And Biostatistics Unit, And Molecular Immunology And Oncology Unit, Veneto Institute of Oncology - IRCCS, 35128 - Padova/IT
  • 3 Radiation Therapy And Nuclear Medicine Unit, Veneto Institute of Oncology - IRCCS, 35100 - Padova/IT


Abstract 3943


GBM PTS can show changes in CF during the treatment which can affect their daily lives. We analyzed QoL, PSY and CF in these PTS treated with RT plus TMZ.


PTS with newly histologically diagnosed GBM treated with RT and TMZ as first-line therapy and KPS ≥ 60 were enrolled. We assessed QoL using EORTC QLQ-C30 and BN20. CF were evaluated with MMSE, and PSY with HADS test. Evaluations were performed at each radiological assessment: T0 (before treatment), T1 (1 month after RT + TMZ), T2 (6 ms from T0), T3 (9 ms from T0) and T4 (12 ms from T0). A repeated-measure linear mixed-model was used to estimate group differences over time and χ2 test for compare mean values at each time.


we enrolled 112 PTS, median age was 59; 69 PTS were male and 36 PTS aged ≥65. All PTS were treated with TMZ until disease progression. Role functioning (RF) statistically improved over time in female (p = 0.02) and PTS


Some variables related to QoL, PSY and CF may improve during standard treatment with RT and TMZ in PTS with GBM. Moreover, age, gender and site of lesion might impact on specific factors. Radiological progression may correlate with worsening of specific points for QoL, PSY and CF.

Clinical trial identification

Legal entity responsible for the study





All authors have declared no conflicts of interest.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings